加压素
利尿剂
内分泌学
兴奋剂
内科学
去氨加压素
类阿片
可乐定
利尿
抗利尿药
加压素受体
化学
医学
药理学
受体
敌手
肾
作者
J. David Leander,Robert L. Zerbe,John C. Hart
出处
期刊:PubMed
日期:1985-08-01
卷期号:234 (2): 463-9
被引量:86
摘要
The effects of agonists at kappa, mu and delta opioid receptors were determined on vasopressin levels in water-deprived rats. Bremazocine and U-50, 488 (kappa agonists) markedly suppressed vasopressin levels, whereas morphine and methadone (mu agonists) and metkephamid (a mixed mu and delta agonist) did not suppress vasopressin levels. Likewise, clonidine, a potent diuretic in normally hydrated rats, did not clearly suppress vasopressin levels. Metkephamid was shown to have a modest diuretic effect in normally hydrated rats but not in water-deprived rats. The diuretic effects of bremazocine were blocked completely by simultaneous treatment with desmopressin, a synthetic vasopressin-like analog. Desmopressin also blocked the diuretic effect of a waterload, but only partially attenuated the diuretic effect of clonidine. These results support the hypothesis that kappa opioid agonists produce a diuretic effect by suppressing plasma levels of vasopressin, and at higher doses produce a pattern of urination similar to animals lacking vasopressin. By comparison, mu and delta opioid agonists have little effect on vasopressin levels in water-deprived rats.
科研通智能强力驱动
Strongly Powered by AbleSci AI